NovaBridge Biosciences American Depositary Shares
NBP
144 hedge funds and large institutions have $2.61B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 63 increasing their positions, 32 reducing their positions, and 26 closing their positions.
97% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 32
38% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 26
12% more call options, than puts
Call options by funds: $4.42M | Put options by funds: $3.97M
10% more capital invested
Capital invested by funds: $2.38B → $2.61B (+$239M)
6% more funds holding
Funds holding: 136 → 144 (+8)
4.38% more ownership
Funds ownership: 15.99% → 20.37% (+4.4%)
43% less funds holding in top 10
Funds holding in top 10: 14 → 8 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$292M |
| 2 |
Morgan Stanley
New York
|
+$69.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.5M |
| 4 |
ZAM
Zeal Asset Management
Central,
Hong Kong
|
+$51.6M |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
WFM Asia
Road Town, Tortola,
British Virgin Islands
|
-$150M |
| 2 |
CCM
CloudAlpha Capital Management
Hong Kong
|
-$24.3M |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
-$22.8M |
| 4 |
PAMI
Perseverance Asset Management International
George Town,
Cayman Islands
|
-$22.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$19.9M |
NBP Hedge Fund Activity: Q3 2021 in Review
144 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2021, worth a combined $2.61B — up 10% from $2.38B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new NBP positions and 26 closed out — a net gain of 10 holders — while 63 added to existing stakes and 32 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $292M. The largest seller was WFM Asia, exiting entirely with an estimated $150M sold.
- 144 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2021, up from 136 in Q2 2021.
- Funds reported $2.61B of NovaBridge Biosciences American Depositary Shares stock for Q3 2021, up 10% quarter-over-quarter.
- 36 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2021 and 26 closed out, a net change of +10 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2021 was T. Rowe Price Associates, an estimated $292M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2021 was WFM Asia, an estimated $150M sold.
Based on aggregated 13F filings for Q3 2021.